Psychosis Clinical Trial
— AMP SCZOfficial title:
Accelerating Medicines Partnership® Schizophrenia Observational Study: Psychosis Risk Evaluation, Data Integration, and Computational Technologies -Data Processing, Analysis, and Coordination Center and Coordination Center
The Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) is a large international collaboration to develop algorithms using a set of clinical and cognitive assessments, multi-modal biomarkers, and clinical endpoints that can be used to predict the trajectories and outcomes of individuals at clinical high risk (CHR) for psychosis and to advance the testing of pharmacological interventions for CHR individuals in need. The goal is to accurately predict which individuals are likely to remit, experience an acute psychotic episode, or have intermediate outcomes that feature persistent attenuated psychotic and/or mood symptoms along with functional impairment. The prediction algorithms will have the potential to serve as early indicators of treatment efficacy in CHR persons. The AMP SCZ research program is made up of the Psychosis Risk Evaluation, Data Integration, and Computational Technologies - Data Processing, Analysis and Coordination Center (PREDICT-DPACC) and two clinical research networks, the Psychosis-Risk Outcomes Network (ProNET) and the Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) networks. The two clinical research networks will recruit a large cohort of CHR young people aged 12-30 years (n=1,977) and healthy control (HC) participants (n=640) across 42 participating investigative sites from 13 countries. CHR participants will complete screening, baseline assessments and a battery of follow-up assessments across 18 - 24 months. HC participants will complete screening and baseline assessments and a subset (5 per site) will complete month 2, 12 and 24 visits.
Status | Recruiting |
Enrollment | 2617 |
Est. completion date | May 31, 2025 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 30 Years |
Eligibility | Inclusion Criteria: - Individuals between 12 and 30 years old; - Understand and sign an informed consent (or assent for minors) document; - Meet diagnostic criteria for CHR from the Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS (PSYCHS). Exclusion Criteria: - Antipsychotic medication exposure equivalent to a total lifetime haloperidol dose of >50 mg or current antipsychotic medication at time of screening assessment; - Documented history of intellectual disability; - Past or current clinically relevant central nervous system disorder; - Traumatic brain injury that is rated as 7 or above on the Traumatic Brain Injury screening instrument; - Current or past treated or untreated psychotic episode, as determined using the PSYCHS. See also the AMP SCZ website link for a description of eligibility criteria (https://www.ampscz.org/participate/eligible/). |
Country | Name | City | State |
---|---|---|---|
Australia | HEP and co-located Headspace Adelaide | Adelaide | South Australia |
Australia | Headspace, Craigieburn | Craigieburn | Victoria |
Australia | Headspace, Glenroy | Glenroy | Victoria |
Australia | Headspace Melton | Melton South | Victoria |
Australia | Orygen Specialist Programs, Melbourne | Parkville | Victoria |
Australia | Headspace, Sunshine | Sunshine | Victoria |
Australia | Headspace, Werribee | Werribee | Victoria |
Canada | University of Calgary | Calgary | Alberta |
Canada | McGill University | Montréal | Quebec |
Chile | Hospital Clínico Universidad de Chile (HCUCH) | Santiago | Región Metropolitana |
China | Shanghai Jiao Tong University | Shanghai | |
Denmark | Copenhagen Research Center for Mental Health (CORE) | Copenhagen | |
Germany | Klinik für Psychiatrie und Psychotherapie, University of Cologne | Cologne | Brescia |
Germany | The University Hospital Jena, Department of Psychiatry | Jena | Thuringia |
Germany | Ludwig-Maximilians-Universität Munich | Munich | |
Hong Kong | The University of Hong Kong, Department of Psychiatry | Hong Kong | |
Italy | University of Pavia | Pavia | |
Korea, Republic of | Department of Psychiatry, Chonnam National University Hospital & Mindlink | Gwangju | |
Korea, Republic of | Seoul National University College of Medicine | Seoul | |
Singapore | Early Psychosis Intervention Programme (EPIP) Clinic, Institute of Mental Health | Singapore | |
Spain | Instituto de Psiquiatría y Salud Mental Hospital General Universitario Gregorio Marañón | Madrid | |
Switzerland | Treatment and Early Intervention in Psychosis Program (TIPP) & Center for Psychiatric Neuroscience (CNP), Department of Psychiatry, Lausanne University Hospital | Lausanne | |
United Kingdom | Forward Thinking Birmingham | Birmingham | |
United Kingdom | University of Cambridge | Cambridge | |
United Kingdom | King's College London | London | |
United States | University of Georgia | Athens | Georgia |
United States | Beth Israel Deaconess Medical Center | Boston | Massachusetts |
United States | University of North Carolina at Chapel Hill | Chapel Hill | North Carolina |
United States | University of Oregon | Eugene | Oregon |
United States | Northwestern University | Evanston | Illinois |
United States | Hartford Healthcare | Hartford | Connecticut |
United States | University of California Irvine | Irvine | California |
United States | University of California Los Angeles | Los Angeles | California |
United States | Yale University/Connecticut Mental Health Center | New Haven | Connecticut |
United States | Icahn School of Medicine at Mount Sinai | New York | New York |
United States | Temple University | Philadelphia | Pennsylvania |
United States | University of Pennsylvania | Philadelphia | Pennsylvania |
United States | University of Pittsburgh | Pittsburgh | Pennsylvania |
United States | Northwell Health | Queens | New York |
United States | Washington University | Saint Louis | Missouri |
United States | University of California San Diego | San Diego | California |
United States | University of California San Francisco | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
Brigham and Women's Hospital | National Institute of Mental Health (NIMH), Orygen, Yale University |
United States, Australia, Canada, Chile, China, Denmark, Germany, Hong Kong, Italy, Korea, Republic of, Singapore, Spain, Switzerland, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Conversion to Psychosis | Conversion to psychosis as defined by psychosis threshold criteria on the PSYCHS. | By 24 month follow-up. | |
Secondary | Remission | Recovery from CHR as defined by PSYCHS criteria. | By 24 month follow-up. | |
Secondary | Non-conversion/Non-remission | Continued CHR condition as defined by PSYCHS criteria. | By 24 month follow-up. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04929938 -
Application of UP for Transdiagnostic Treatment of Emotional Disorders for UHR for Psychosis Patients
|
N/A | |
Recruiting |
NCT05863572 -
Strengthening Care in Collaboration With People With Lived Experience of Psychosis in Uganda
|
N/A | |
Completed |
NCT04277585 -
Improving Access to Early Psychosis Coordinated Specialty Care
|
N/A | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Terminated |
NCT04404712 -
FAAH Availability in Psychiatric Disorders: A PET Study
|
Early Phase 1 | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Not yet recruiting |
NCT05558332 -
Youth Nominated Support Team
|
N/A | |
Not yet recruiting |
NCT05358457 -
Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf)
|
N/A | |
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Completed |
NCT02895269 -
COllaborative Shared Care to IMprove Psychosis Outcome
|
N/A | |
Recruiting |
NCT02622048 -
Understanding and Helping Families: Parents With Psychosis
|
N/A | |
Completed |
NCT02733575 -
Compassion Focused Therapy for Distressing Experiences
|
N/A | |
Completed |
NCT02653729 -
Cbt for Psychosis and Affect on Psychosis Symptoms
|
Phase 2 | |
Completed |
NCT02531243 -
Computer-Aided Learning for Managing Stress
|
N/A | |
Not yet recruiting |
NCT02244970 -
Mindfulness RCT for Early Psychosis
|
N/A | |
Enrolling by invitation |
NCT01364818 -
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
|
N/A | |
Withdrawn |
NCT00786318 -
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
|
Phase 4 | |
Recruiting |
NCT00722163 -
A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis
|
Phase 0 |